Skip to main content
|

Add a bookmark to get started

Bookmarks info

Andrzej Balicki Ph.D.

Partner
Head of Regulatory
A clear leader and is my first contact point in all matters. Andrzej is very energetic, pragmatic and solution-oriented. He has market-leading regulatory knowledge. He has great understanding of legal and business aspects of public affairs projects. Andrzej is known for his strategic thinking and ability to implement it in practice.
— The Legal 500 EMEA, Healthcare and life sciences 2022
Warsaw
About

Andrzej Balicki works extensively with clients from highly regulated industries, in particular life sciences and food. His practice covers regulatory counselling with respect to medicinal products, medical devices, diet supplements and foodstuffs.

Andrzej also has extensive regulatory experience under the Polish and EU law and represents clients in high-profile antitrust and public procurement cases in life sciences and energy projects.

Areas of FocusHealthcareIndustrialsLife SciencesIntellectual PropertyRegulatory and Government AffairsTechnology
Professional QualificationsAttorney-at-law (Radca prawny) registered with the Warsaw Bar Association of Attorneys-at-Law (Okręgowa Izba Radców Prawnych w Warszawie)

EXPERIENCE

  • Advising many well-known pharmaceutical and healthcare companies, both local and international ones, on pharmaceutical and medical regulatory compliance matters, antitrust law, as well as on public procurement issues
  • Representing one of the world's leading engineering and construction companies in a number of public procurement proceedings concerning the construction of power plants in Poland, including representation before the National Chamber of Appeals and regional courts
  • Representing a big Polish energy company, part of the biggest Polish energy group, on court proceedings against the decision of the President of the Energy Regulatory Office concerning state aid in the form of reimbursement of so-called stranded costs
  • Assistance and advice to one of the world's leading providers of defence technology during negotiation rounds concerning business agreements fulfilling the offset commitments, in particular competition law aspects of technology transfer agreements
  • Advising one of the world’s leading food companies in relation to its EU-enforced sale of a business in Poland, on regulatory aspects of the sale transaction
Languages
  • Polish
  • English
Education
  • University of Warsaw, Ph.D. - Regulation of pharmaceuticals

Awards

  • Recommended for Healthcare and Life sciences, Public Procurement and Competition/Antitrust - Legal 500 EMEA, 2022
  • "Andrzej Balicki has extensive experience in advising the life sciences sector and is highly respected in the industry. He is a creative and client-focused problem solver. He is certainly a leading regulatory lawyer in Poland." - Legal 500 EMEA, 2022

Insight Overview

Andrzej holds seminars to brief clients on regulatory issues in the life sciences sector and on food-related issues, including labelling and advertising, product safety and the structuring of distribution networks. He is also an author of regular sector-specific articles and provides commentaries on regulatory changes and ambiguities in new legal provisions.

Andrzej is the co-author of the first commentary on the Polish Food Law (Wolters Kluwer, 2013) and the first Polish commentary on Regulation (EC) No. 1924/2006 on nutrition and health claims (Wolters Kluwer, 2015).

Memberships And Affiliations

  • Andrzej is an active member of the Experts Council at The Polish Council for Supplements and Nutritional Foods (KRSiO)

My latest insights

Publication
image

Pharmaceutical and medical sector report

23 January 2023 .3 minute read

News
image

DLA Piper rozwija praktykę prawa ochrony środowiska

11 May 2021 .2 minute read

Connect

Phone

+48 22 540 74 01
(Work, Warsaw)
CallvCardLinkedInPrint
Privacy policyLegal noticesCookie policyModern slaveryWhistleblowingSitemap

DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.

© 2023 DLA Piper